Multiple Myeloma | What Clinicians Want to Know About Anti-CD38 Antibodies in the Management of Multiple Myeloma

Research To Practice | Oncology Videos · Oct 9, 2023 · 47m

Featuring an interview with Prof Philippe Moreau, including the following topics:

Perspectives on efficacy outcomes with and toxicity profiles of daratumumab and isatuximab (0:00)

Selection of an anti-CD38 antibody for initial treatment of multiple myeloma (MM) (7:28)

Approach to maintenance therapy for transplant-eligible patients with MM (15:47)

Management of MM in older patients; treatment approaches for t(11;14) MM (22:47)

Management of relapsed/refractory MM (29:49)

Management of anti-CD38 antibody-associated side effects (35:45)

Other relevant clinical scenarios in MM — Plasma cell…